SAUHY
Straumann Holding AG
OTC Markets OTCPKUSDEQUITY
Healthcare
DELAYED
Last price
11.56
▼ 0.39 (3.26%)
MARKET · —
Price
Open
11.60
Prev close
11.95
Day high
11.60
Day low
11.48
Volume
14.03K
Market cap
$18.74B
P/E (TTM)
39.86
52W range
9.44 – 13.61
Trailing performance
Returnvs SPY
1W
-7.89%
-6.5%
1M
-1.70%
-5.4%
3M
-1.03%
-4.1%
6M
-4.70%
-15.8%
YTD
-0.77%
-13.1%
1Y
-3.51%
-23.5%
3Y
-23.95%
-98.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$18.74B
Enterprise value$18.45B
Revenue (TTM)$2.64B
Gross profit$1.83B
EBITDA$750.60M
Net income$369.18M
EPS (TTM)$0.29
Free cash flow$399.02M
Total cash$414.60M
Total debt$474.62M
Book value / share$1.65
Shares outstanding1.59B
Float1.08B
Short % of float—
Dividend yield1.10%
Beta (5Y)1.38
Valuation & profitability ratios
Trailing P/E39.86
Forward P/E23.77
PEG ratio1.34
Price / sales—
Price / book6.99
EV / revenue7.00
EV / EBITDA24.58
Gross margin69.26%
Operating margin25.14%
Profit margin14.00%
Return on equity17.05%
Return on assets10.99%
Debt / equity20.76
Current ratio2.26
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $2.61B | $2.50B | $2.41B | $2.32B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $358.00M | $459.00M | $246.07M | $434.79M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $358.00M | $459.00M | $246.07M | $434.79M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $637.00M | +5.8% |
| Next quarter | — | — | $698.40M | +6.6% |
| Current year | 0.41 | 1 | $2.77B | +6.2% |
| Next year | 0.49 | 1 | $3.04B | +9.8% |
Analyst targets & ownership
Mean target$15.00
High target$15.00
Low target$15.00
Implied upside29.76%
Analyst count1
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders0.00%
Held by institutions0.02%
Institutions holding8
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Moving averages & technicals
SMA 10
12.34
-6.31% from price
SMA 20
12.43
-6.97% from price
SMA 50
12.54
-7.78% from price
SMA 100
11.81
-2.15% from price
SMA 200
11.78
-1.88% from price
EMA 12
12.24
-5.58% from price
EMA 26
12.36
-6.48% from price
EMA 50
12.30
-5.98% from price
RSI (14)
34.2
Neutral
MACD (12,26,9)
-0.12
Hist -0.10
ATR (14)
0.31
2.72% of price
Realised vol 30D
30.8%
Annualised
Bollinger upper
13.12
20, 2σ
Bollinger lower
11.73
20, 2σ
50 / 200 cross
Golden
12.54 vs 11.78
Trend bias
Below 200
-1.88%
Risk profile
Beta vs SPY
0.86
Less volatile than market
Correlation to SPY
0.33
Loosely linked
Realised vol 30D
30.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-27.6%
Peak to trough
Max drawdown 5Y
-50.2%
Peak to trough
ATR 14
0.31
2.72% of price
Beta (reported)
1.38
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Health Care Roundup: Market Talk
The Wall Street Journal · 1d ago
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
Zacks · 16d ago
ALGN vs. SAUHY: Which Stock Is the Better Value Option?
Zacks · 40d ago
ALGN or SAUHY: Which Is the Better Value Stock Right Now?
Zacks · 58d ago
Straumann Shares Climb After Lower-Than-Expected Tariffs Boost Outlook
The Wall Street Journal · 66d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.